Clinical Trial Update: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia [Phase 1]

View source ↗

Summary

This clinical trial update summarizes Phase I results for GNKG168 in relapsed acute lymphoblastic leukemia and relapsed acute myeloid leukemia. The study was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• GNKG168

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Relapsed Acute Lymphoblastic Leukemia, Relapsed Acute Myelogenous Leukemia | Phase 1 | Status: TERMINATED | Results posted: 2025-01-27